Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase - PubMed

Affiliations

• PMID: 18063801
• DOI: 10.1126/science.1148045

Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase

M Margarita Behrens et al. Science. 2007.

Abstract

Abuse of the dissociative anesthetic ketamine can lead to a syndrome indistinguishable from schizophrenia. In animals, repetitive exposure to this N-methyl-d-aspartate-receptor antagonist induces the dysfunction of a subset of cortical fast-spiking inhibitory interneurons, with loss of expression of parvalbumin and the gamma-aminobutyric acid-producing enzyme GAD67. We show here that exposure of mice to ketamine induced a persistent increase in brain superoxide due to activation in neurons of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Decreasing superoxide production prevented the effects of ketamine on inhibitory interneurons in the prefrontal cortex. These results suggest that NADPH oxidase may represent a novel target for the treatment of ketamine-induced psychosis.

Similar articles

• Reactive Oxygen Species-mediated Loss of Phenotype of Parvalbumin Interneurons Contributes to Long-term Cognitive Impairments After Repeated Neonatal Ketamine Exposures.

  Zhang H, Sun XR, Wang J, Zhang ZZ, Zhao HT, Li HH, Ji MH, Li KY, Yang JJ. Zhang H, et al. Neurotox Res. 2016 Nov;30(4):593-605. doi: 10.1007/s12640-016-9653-1. Epub 2016 Jul 21. Neurotox Res. 2016. PMID: 27443555

• Sepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice.

  Ji MH, Qiu LL, Tang H, Ju LS, Sun XR, Zhang H, Jia M, Zuo ZY, Shen JC, Yang JJ. Ji MH, et al. J Neuroinflammation. 2015 Sep 29;12:182. doi: 10.1186/s12974-015-0401-x. J Neuroinflammation. 2015. PMID: 26416717 Free PMC article.

• Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats.

  Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M, Cuomo V, Trabace L, Krause KH. Schiavone S, et al. Biol Psychiatry. 2009 Aug 15;66(4):384-92. doi: 10.1016/j.biopsych.2009.04.033. Epub 2009 Jun 26. Biol Psychiatry. 2009. PMID: 19559404

• Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?

  Behrens MM, Sejnowski TJ. Behrens MM, et al. Neuropharmacology. 2009 Sep;57(3):193-200. doi: 10.1016/j.neuropharm.2009.06.002. Epub 2009 Jun 11. Neuropharmacology. 2009. PMID: 19523965 Free PMC article. Review.

• The acute effects of NMDA antagonism: from the rodent to the human brain.

  Gunduz-Bruce H. Gunduz-Bruce H. Brain Res Rev. 2009 May;60(2):279-86. doi: 10.1016/j.brainresrev.2008.07.006. Epub 2008 Jul 30. Brain Res Rev. 2009. PMID: 18703087 Review.

Cited by

• Glutamatergic dysbalance and oxidative stress in in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism.

  Genius J, Geiger J, Dölzer AL, Benninghoff J, Giegling I, Hartmann AM, Möller HJ, Rujescu D. Genius J, et al. PLoS One. 2013 Jul 15;8(7):e59395. doi: 10.1371/journal.pone.0059395. Print 2013. PLoS One. 2013. PMID: 23869202 Free PMC article.

• ROS upregulation during the early phase of retroviral infection plays an important role in viral establishment in the host cell.

  Kim SJ, Wong PKY. Kim SJ, et al. J Gen Virol. 2013 Oct;94(Pt 10):2309-2317. doi: 10.1099/vir.0.055228-0. Epub 2013 Jul 24. J Gen Virol. 2013. PMID: 23884362 Free PMC article.

• GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

  Gandal MJ, Sisti J, Klook K, Ortinski PI, Leitman V, Liang Y, Thieu T, Anderson R, Pierce RC, Jonak G, Gur RE, Carlson G, Siegel SJ. Gandal MJ, et al. Transl Psychiatry. 2012 Jul 17;2(7):e142. doi: 10.1038/tp.2012.69. Transl Psychiatry. 2012. PMID: 22806213 Free PMC article.

• Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes.

  Fujihara K, Miwa H, Kakizaki T, Kaneko R, Mikuni M, Tanahira C, Tamamaki N, Yanagawa Y. Fujihara K, et al. Neuropsychopharmacology. 2015 Sep;40(10):2475-86. doi: 10.1038/npp.2015.117. Epub 2015 Apr 23. Neuropsychopharmacology. 2015. PMID: 25904362 Free PMC article.

• Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system.

  Datta MS, Chen Y, Chauhan S, Zhang J, De La Cruz ED, Gong C, Tomer R. Datta MS, et al. Cell Rep. 2023 Dec 26;42(12):113491. doi: 10.1016/j.celrep.2023.113491. Epub 2023 Dec 4. Cell Rep. 2023. PMID: 38052211 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database